SEARCH:   Advanced

Blood, Vol. 109, Issue 5, 1834-1840, March 1, 2007 This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor Blood Stabile et al. 109: 1834 Supplemental materials for: Stabile et al, Vol 109, Issue 4, 1834-1840 Files in this Data Supplement: Figure S1. Proangiogenic activity of Drm expressed in COS cells (PDF, 1.01 MB) - Cell extracts from mock- and Drm-transfected COS cells were probed in a Western blot with anti-Drm antibody (a). Mock-COS (b) and Drm-COS cells (c) were implanted via a gelatin sponge on the top of the CAM at day 8. CAMs were photographed after 4 days. This Article Abstract Full Text Services Email this article to a friend Alert me to new issues of the journal Rights and Permissions Citing Articles Citing Articles via CrossRef

	Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020